1.Quantities of Receptor Molecules for Colony Stimulating Factors on Leukocytes in Measles.
You Jeong KIM ; So Young KIM ; Young Yoo KIM ; Jong Wan KIM ; Je Hoon LEE ; Kyung Ja HAN ; Won Bae LEE
Yonsei Medical Journal 2002;43(1):43-47
We analyzed the comparative amounts of granulocyte-colony stimulating factor (G-CSFr) and granulocyte macrophage CSF (GM-CSFr) receptors expressed on neutrophils and monocytes in measles patients to investigate the role of these CSFrs in the development of leukopenia including neutropenia and monocytopenia in measles. EDTA-anticoagulated peripheral blood of 19 measles patients, 10 children with other infections showing leukopenia and 16 children with normal complete blood cell counts (CBC)s were analyzed using flow cytometry and QuantiBRITE. The leukocyte (5260 +/- 2030/uL vs. 9900 + 2680/uL, p=0.000), neutrophil (2580 +/- 960/uL vs. 4250 +/- 2750/uL, p=0.024) and the lymphocyte counts of measles patients (1810 +/- 1430/uL vs. 4530 +/- 3450/uL, p= 0.006) were lower than in the normal controls. The neutrophils of measles patients expressed similar amounts of G- CSFr (1858 +/- 355) as normal children (1764 +/- 477, p= 0.564) and leukopenic patients (1773 +/- 673, p=0.713), but lower levels of GM-CSFr (535 +/- 118) than normal children (957 +/- 344, p=0.000) and leukopenic patients (832 +/- 294, p=0.002). The monocytes of measles patients expressed similar amounts of G-CSFr (916 +/- 336) and GM-CSFr (3718 +/- 906) as normal children (1013 +/- 391 and 4125 (2645, p > 0.05) but less than leukopenic patients (1454 +/- 398 and 5388 +/- 806, p > 0.05). The neutrophil and monocyte counts of measles patients did not correlate with the amount of G-CSFr or GM-CSFr expressed on neutrophils or monocytes (p > 0.05), but in the normal children, the monocyte count correlated with the levels of GM-CSFr on monocytes (r=0.951, p=0.049). In conclusion, neutropenia is one of the more important characteristics of measles patients, which could be due to the decreased GM-CSFr expression on neutrophils. However, the monocytopenia found in measles patients is not due to the decreased expression of CSFr on the monocytes.
Human
;
Leukocyte Count
;
Measles/*blood
;
Monocytes/*chemistry
;
Neutropenia/etiology
;
Neutrophils/*chemistry
;
Receptors, Granulocyte Colony-Stimulating Factor/*blood
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*blood
2.Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes.
Kyo Young LEE ; Byung Gyu SUH ; Jong Wan KIM ; Won Bae LEE ; So Young KIM ; Young Yoo KIM ; Je Hoon LEE ; Ji Hyang LIM ; Myung Shin LIM ; Chang Suk KANG ; Kyung Ja HAN
Experimental & Molecular Medicine 2000;32(4):210-215
Administration of G-CSF may not always respond in rise of neutrophil counts in different patient population. In order to understand a possible inter-relationship between the G-CSF and GM-CSF induced leukocyte responses and expression levels of receptors for G-CSF (G-CSFr) and GM-CSF (GM-CSFr), the levels of each receptor and CSF were measured in patients with basophilia (8), eosinophilia (14) and bacterial infection showing neutrophilia (12) in comparison with normal healthy adults (12) and children (14). G-CSFr was expressed in neutrophils in the largest amount followed by monocytes, but GM-CSFr was expressed more in monocytes than neutrophils. Lymphocytes and basophils did not express G-CSFr or GM-CSFr. The amount of GM-CSFr in neutrophils was present less in patients with infection than normal control (P = 0.031). The neutrophils expressed more G-CSFr than GM-CSFr. The quantity of G-CSFr in eosinophil showed marked interval change, higher in acute stage. The plasma concentrations of G-CSF in patients with infection were much higher than normal adults or children (117.95 +/- 181.16 pg/ml, P < 0.05). Binding assay with excess amount of CSFs could discriminate the patient who did not show any response to G-CSF or GM-CSF administration. After incubation with excess CSFs, more receptors were blocked in children than in adults (G-CSF P = 0.024, GM-CSF P = 0.006). These results indicate that the amount of CSFr in leukocyte varies in different types of leukocyte, and changes according to the patients' condition even in the same type of leukocyte, and the CSFrs of children bind to CSFs more than those of adults.
Adult
;
*Bacterial Infections
;
Basophils/chemistry
;
Breast Neoplasms
;
Child
;
Colony-Stimulating Factors/*blood
;
Eosinophilia
;
Human
;
Leukemia, Myeloid, Chronic
;
*Leukocyte Disorders
;
Monocytes/chemistry
;
*Neoplasms
;
Neutrophils/chemistry
;
Receptors, Colony-Stimulating Factor/*analysis
;
Receptors, Granulocyte Colony-Stimulating Factor/analysis
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/analysis
3.Expression of soluble GM-CSF-Ralpha in patients with acute myeloid leukemia.
Rong XIAO ; Ri ZHANG ; You-Liang WANG ; Zi-Ling ZHU ; Tao CHEN ; Jian-He YANG
Journal of Experimental Hematology 2006;14(2):225-227
To evaluate soluble GM-CSF-Ralpha expression in patients with acute myeloid leukemia (AML) and its clinic significance, plasma concentration of solGM-Ralpha in de novo 66 patients with AML was detected by enzyme-linked immuno-sorbent assay, and the relationship between solGM-Ralpha levels and various clinical parameters was analyzed. The result showed that the levels of solGM-Ralpha in plasma of patients with AML were significantly higher than that in plasma of normal controls; the lowest level of solGM-Ralpha was found in plasma of patients with AML-M3 (3897.75 +/- 2651.43 pg/ml), the highest level of solGM-Ralpha was observed in plasma of patients with AML-M5 (9990.92 +/- 6325.43 pg/ml). Patients with high level of solGM-Ralpha were generally accompanied with a distinct clinical picture, including higher counts of white blood cell and myeloid precursors, as well as higher expression of CD34, CD95 and CD116 antigen. It is concluded that the high level of solGM-Ralpha in plasma of patients may suggest AML poor prognosis and play a role in pathogenesis of leukemia, the GM-CSF and its receptor solGM-Ralpha needs further study.
Adolescent
;
Adult
;
Aged
;
Antigens, CD34
;
blood
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Humans
;
Leukemia, Myeloid, Acute
;
blood
;
Male
;
Middle Aged
;
Prognosis
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
;
biosynthesis
;
blood
;
fas Receptor
;
blood
4.In vitro expansion of cord blood mononuclear cells supported by fetal bone marrow stromal cells and cytokines.
Ping MAO ; Cai-Xia WANG ; Xiu-Mei LIN ; Qing-Hua DU
Journal of Experimental Hematology 2005;13(3):422-428
This study was aimed to explore the role of human fetal bone marrow stromal cells (FBMSC) in combination with exogenous cytokines in supporting the in vitro expansion of cord blood mononuclear cells and the expression of CXCR4(+) and CD49d(+) in CD34(+) cells. Mononuclear cells (MNC) separated from cord blood (CB) were cultured in a serum-free support culture system with FBMSC or exogenous cytokines or both of them. On day 0, 6, 10 and 14, total cells were counted, CD34(+), CD34(+)CXCR4(+) and CD34(+)CD49d(+) cells were quantitated by FACS, and hematopoietic progenitor cells were assessed by semisolid culture assay. The results showed that after culturing for 14 days, CD34(+) cells, CD34(+)CXCR4(+) cells, CD34(+) CD49d(+) cells and colony forming unit (CFU) were significantly increased (P < 0.05). Compared with other groups, expansion multiple of CD34(+), CD34(+)CXCR4(+), CD34(+)CD49d(+) cells and CFU were higher than that in FBMSC and cytokine group (P < 0.05). It is concluded that the culture system used in this study can not only support the expansion of CB MNCs but also increase the number of hematopoietic stem and progenitor cells which has chemokine and adhesion capacity. This culture system may be a feasible way for in vitro culture of cord blood cells.
Antigens, CD34
;
blood
;
Bone Marrow Cells
;
cytology
;
immunology
;
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Coculture Techniques
;
Cytokines
;
pharmacology
;
Fetal Blood
;
cytology
;
Fetus
;
Flow Cytometry
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
pharmacology
;
Humans
;
Integrin alpha4
;
blood
;
Interleukin-3
;
pharmacology
;
Leukocytes, Mononuclear
;
cytology
;
immunology
;
Receptors, CXCR4
;
blood
;
Stromal Cells
;
cytology
;
immunology
;
Time Factors
5.Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice.
Xue-Dong DAI ; Miao YIN ; Wen JING ; Hui-Qin DU ; Hong-Yan YE ; Yun-Ju SHANG ; Liang ZHANG ; Yan-Yan ZOU ; Zhi-Ping QU ; Jie PAN
Acta Physiologica Sinica 2008;60(1):43-50
To systematically clarify the effects of apolipoprotein E (aopE) and low-density lipoprotein receptor (LDLR) gene mutant on hyperlipidemia, vascular inflammation impairment and pathogenesis of atherosclerosis (AS), total RNA was isolated from fresh aortas of young apoE/LDLR double knockout (apoE(-/-)/LDLR(-/-)) and wild type (WT) mice using TRIzol reagent. Then RNA was reversely transcribed to first-strand cDNA by reverse transcriptase for reverse transcription polymerase chain reaction (RT-PCR) and real-time RT-PCR. Primer pairs were designed using primer design software according to the gene sequences available in GenBank. β-actin was used as an internal control. Then RT-PCR assay was used to analyze the expression patterns of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), nuclear factor-κB (NF-κB), granulocyte-macrophage colony-stimulating factor (GM-CSF), CD36, endothelin-1 (ET-1), toll-like receptor 2 (TLR2), monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and platelet-derived growth factor-α (PDGF-α). SYBR Green quantitative real-time RT-PCR was used to validate gene expressions identified by RT-PCR. Blood samples were taken from the retro-orbital venous plexus, and serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) were measured by using biochemical techniques. Serum concentrations of circulating TNF-α, IL-1β and oxidized LDL (ox-LDL) were determined by ELISA. Frozen sections of aortic sinus were stained with Sudan IV to visualize intimal fatty lesions. The results showed that the relative expressions of IL-1β, GM-CSF, ET-1, TLR2, CD36, MCP-1, ICAM-1 and VCAM-1 in apoE(-/-)/LDLR(-/-) mice at the age of 1 month were higher than those in age-matched WT mice (P<0.05, P<0.01), respectively. The expressions of PDGF-α and TNF-α in apoE(-/-)/LDLR(-/-) mice at the age of 2 months were up-regulated compared to those in age-matched WT mice (P<0.05). All the expressions of target genes continued to be up-regulated (P<0.05, P<0.01) except that ET-1 expression at the age of 2 months, TLR2, VCAM-1 and ICAM-1 expressions at the age of 3 months were down-regulated to that in WT mice. NF-κB expression had no significant changes between two genotype mice at different ages. All the gene expressions kept unchanged in WT mice at different ages, except that IL-1b expressions were slightly up-regulated at the ages of 2 and 3 months. Serum levels of TC, TG, LDL, HDL, TNF-α, IL-1β and ox-LDL in apoE(-/-)/LDLR(-/-) mice at different ages were higher than those in age-matched WT mice (P<0.05, P<0.01), and were increasing with age. Primary atherosclerotic lesions were observed in 1-month old apoE(-/-)/LDLR(-/-) mice and were progressing with age. There were no lesions observed in all WT mice at different ages. The data suggest that hyperlipidemia due to apoE and LDLR gene mutant may stimulate the temporal expressions of AS-related genes and contribute to primary atherogenetic lesions and vascular inflammation impairment.
Animals
;
Aorta
;
metabolism
;
Apolipoproteins E
;
genetics
;
Atherosclerosis
;
genetics
;
CD36 Antigens
;
metabolism
;
Chemokine CCL2
;
metabolism
;
Endothelin-1
;
metabolism
;
Gene Expression
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
metabolism
;
Hyperlipidemias
;
metabolism
;
Intercellular Adhesion Molecule-1
;
metabolism
;
Interleukin-1beta
;
blood
;
metabolism
;
Lipoproteins, LDL
;
blood
;
Mice
;
Mice, Knockout
;
NF-kappa B
;
metabolism
;
Platelet-Derived Growth Factor
;
Receptors, LDL
;
genetics
;
Toll-Like Receptor 2
;
metabolism
;
Tumor Necrosis Factor-alpha
;
blood
;
metabolism
;
Vascular Cell Adhesion Molecule-1
;
metabolism